plasmacytoid
dendrit
cell
pdc
special
rapid
massiv
secret
type
interferon
respons
foreign
nucleic
acid
combin
antigen
present
capac
power
function
enabl
pdc
orchestr
innat
adapt
immun
respons
pdc
combin
featur
lymphocyt
classic
dendrit
cell
display
uniqu
molecular
adapt
nucleic
acid
sens
ifn
product
decad
sinc
identif
pdc
distinct
immun
cell
type
understand
molecular
underpin
role
immun
progress
rapidli
review
select
aspect
pdc
biolog
includ
cell
fate
establish
plastic
specif
molecular
mechan
pdc
function
role
pdc
cell
respons
antivir
immun
autoimmun
diseas
import
unresolv
question
remain
area
promis
excit
time
pdc
research
year
come
type
interferon
dendrit
cell
innat
immun
antigen
present
note
author
plasmacytoid
dendrit
cell
pdc
one
recent
addit
palett
immun
cell
type
sinc
first
unequivoc
character
pdc
knowledg
cell
associ
volum
public
increas
dramat
refer
first
review
pdc
seri
publish
nearli
key
aspect
pdc
biolog
recent
review
elsewher
given
vast
materi
avail
recent
review
extraordinari
pace
progress
comprehens
overview
field
neither
feasibl
necessari
instead
highlight
sever
key
aspect
pdc
biolog
function
incomplet
understood
requir
elucid
anyth
els
would
like
review
provid
ground
discuss
futur
investig
unfortun
side
effect
select
task
unabl
cover
mani
import
primari
contribut
apolog
author
primari
function
uniqu
properti
pdc
secret
type
interferon
respons
virus
andor
virusderiv
nucleic
acid
pioneer
studi
alm
colleagu
fitzgeraldbocarsli
colleagu
trinchieri
colleagu
identifi
partial
character
specif
minor
subset
human
peripher
blood
leukocyt
respons
highlevel
ifn
product
independ
facchetti
et
al
built
earli
observ
lennert
character
secretori
cell
term
plasmacytoid
monocyt
accumul
human
reactiv
lymph
node
site
inflamm
liu
et
al
show
plasmacytoid
cell
effici
gener
dendrit
cell
dc
vitro
design
type
dc
precursor
final
liu
colonna
group
demonstr
plasmacytoid
monocyt
natur
ifnproduc
cell
fact
cellular
entiti
pdc
converg
line
investig
reflect
key
properti
pdc
power
ifn
product
secretori
plasmacytoid
ie
plasma
celllik
morpholog
abil
differenti
convent
classic
dc
cdc
subsequ
murin
counterpart
human
pdc
identifi
vitro
deriv
pdc
human
murin
hematopoiet
progenitor
establish
advanc
led
deep
genet
mechanist
insight
pdc
develop
function
includ
recent
genomewid
express
proteom
analys
despit
certain
molecular
differ
function
overal
phenotyp
core
gene
express
program
murin
human
pdc
conserv
pdc
rare
human
peripher
blood
murin
lymphoid
organ
cell
develop
bone
marrow
resid
primarili
lymphoid
organ
steadi
state
enter
lymph
node
blood
pdc
round
morpholog
secretori
lymphocyt
turn
rel
slowli
express
low
level
mhc
class
ii
costimulatori
molecul
pdc
low
mous
neg
human
integrin
posit
b
cell
marker
notabl
featur
steadyst
pdc
similar
lymphocyt
distinct
cdc
see
sidebar
classic
convent
dc
cdc
sever
rel
pdcspecif
surfac
marker
establish
human
blood
dendrit
cell
antigen
bdca
immunoglobulinlik
transcript
murin
siglech
use
albeit
less
specif
marker
includ
human
murin
pdc
express
endosom
nucleic
acidsens
tolllik
receptor
tlr
respond
respect
ligand
singlestrand
rna
unmethyl
cpgcontain
dna
cpg
distinct
pdc
respons
stimuli
rapid
abund
ifn
secret
potent
cell
type
fact
secret
respons
cpg
challeng
vivo
mediat
exclus
pdc
suggest
antibodymedi
genet
ablat
ifn
report
strain
analysi
consequ
tlrinduc
pdc
activ
includ
secret
cytokin
mous
acquisit
antigen
present
abil
altogeth
power
immunostimulatori
function
pdc
contribut
recruit
andor
activ
nearli
immun
cell
type
eg
natur
killer
nk
cell
plasma
cell
establish
pdc
key
link
innat
adapt
immun
given
rariti
pdc
complex
phenotyp
caution
need
definit
function
analysi
exampl
definit
pdc
low
clearli
mislead
includ
multipl
addit
cell
type
nklike
cell
cdc
progenitor
convers
use
singl
pdcspecif
marker
may
equal
problemat
instanc
wide
use
murin
pdc
marker
also
express
plasma
cell
broadli
induc
upon
activ
furthermor
isol
human
pdc
base
specif
marker
inhibitori
receptor
impair
ifn
product
capac
boost
frustratingli
low
pdc
number
mice
mani
studi
inject
ligand
express
melanoma
cell
line
approach
discourag
result
gross
tumor
supraphysiolog
level
like
affect
pdc
ground
state
function
anoth
practic
consider
involv
gene
target
mice
crerecombinaseexpress
delet
strain
cellspecif
strain
mediat
effici
offtarget
recombin
pdc
thu
care
analysi
recombin
pdc
requir
exclud
potenti
contribut
phenotyp
condit
target
experi
recent
review
development
origin
transcript
control
pdc
lineag
provid
brief
updat
highlight
sever
issu
await
resolut
futur
studi
point
discuss
incorpor
propos
scheme
pdc
develop
figur
pdc
develop
common
dc
progenitor
cdp
prodc
distinct
progenitor
type
bone
marrow
express
cytokin
receptor
mcsfr
low
level
ckit
noteworthi
ckit
low
broad
definit
lymphoid
progenitor
includ
canon
common
lymphoid
progenitor
clp
moreov
clp
give
rise
pdc
upon
adopt
transfer
inde
least
fraction
pdc
show
evid
lymphoid
deriv
confirm
recent
singlecel
genet
trace
prior
express
revers
trace
system
dcpdcspecif
strain
mediat
delet
lymphocyt
fraction
similar
lymphoid
cell
type
b
nk
cell
earliest
progenitor
b
reizi
unpublish
observ
locat
origin
recombin
minor
subset
low
ckit
low
progenitor
appear
overlap
cdp
andor
predc
also
contribut
lymphopoiesi
suggest
cre
report
trace
thu
pdc
may
develop
less
linear
fashion
suggest
origin
continuum
progenitor
dc
andor
lymphoid
potenti
fulli
commit
pdc
progenitor
ie
lack
cdc
potenti
remain
identifi
may
resid
within
popul
murin
bone
marrow
cytokin
ligand
receptor
essenti
signal
dc
pdc
develop
control
expans
common
progenitor
peripher
dc
homeostasi
notabl
pdc
depend
signal
cdc
pdc
popul
select
diminish
lymphoid
organ
mice
target
delet
mutat
nonfunct
suggest
signal
specif
roleinp
dc
common
progenitor
stage
possibl
promot
termin
pdc
differenti
matur
pdc
surviv
one
import
unresolv
question
molecular
pathway
transduc
signal
pdc
develop
recent
studi
indic
phosphoinositid
depend
activ
mammalian
target
rapamycin
mtor
mediat
signal
dc
particular
pdc
develop
bone
marrow
cultur
exquisit
sensit
mtor
inhibitor
rapamycin
even
ad
low
concentr
late
time
point
larg
spare
cdc
develop
convers
hyperactiv
delet
pten
bone
marrow
greatli
acceler
cdc
pdc
develop
cultur
thu
activ
may
repres
key
signal
event
downstream
dc
progenitor
differenti
pdc
wherea
induc
prolif
expans
common
dcpdc
progenitor
littl
prolifer
appear
occur
pdc
commit
like
explain
technic
challeng
boost
pdc
develop
vivo
inde
administr
expand
popul
cdc
especi
cdc
subset
much
greater
extent
pdc
similarli
pten
delet
bone
marrow
increas
cdc
pdc
number
vivo
appar
perman
quiescenc
distinguish
pdc
lymphocyt
cdc
prolifer
develop
situ
respect
base
rel
slow
brdu
incorpor
rate
pdc
thought
longliv
howev
slow
uptak
may
due
abovement
quiescenc
matur
pdc
moreov
parabiosi
experi
parabiot
partnerderiv
splenic
pdc
disappear
rapidli
surgic
separ
thu
true
life
span
peripher
pdc
remain
establish
combin
approach
gener
regul
pdc
surviv
quiescenc
poorli
understood
would
provid
interest
topic
futur
studi
upregul
basic
helixloophelix
transcript
factor
e
protein
serv
key
lineag
commit
event
pdc
develop
hematopoiet
progenitor
fail
produc
pdc
exact
cellular
stage
induct
unknown
await
analysi
singlecel
report
strain
express
importantli
signal
induct
pdc
remain
obscur
may
repres
solubl
factor
cellassoci
ligand
andor
upstream
transcript
factor
noteworthi
express
signific
level
hematopoiet
stemprogenitor
cell
b
lymphocyt
thu
mere
quantit
severalfold
upregul
underli
pdc
commit
importantli
pdc
show
particularli
low
express
e
protein
inhibitor
contrast
abund
express
nk
myeloid
cell
absenc
express
like
serv
import
counterpart
upregul
increas
effect
concentr
pdc
figur
everi
lineag
commit
step
involv
establish
lineagespecif
gene
express
program
well
suppress
altern
lineag
program
recent
genomewid
analysi
bind
promot
human
pdc
cell
line
suggest
directli
involv
activ
found
bind
larg
fraction
pdcenrich
gene
includ
highli
pdcspecif
gene
addit
appear
bind
directli
repress
sever
hallmark
gene
altern
cdc
fate
itgax
transcript
repress
posttransl
inhibit
suggest
two
factor
repres
pair
reciproc
antagonist
cell
fate
determin
typic
mani
lineag
bifurc
eg
effector
memori
lymphocyt
differenti
addit
eid
protein
antagon
bona
fide
transcript
repressor
like
modul
decis
pdc
altern
eg
cdc
cell
fate
one
like
candid
repressor
promin
express
pdc
requir
pdc
develop
p
tucker
person
commun
found
direct
target
suggest
may
promot
pdc
commit
part
repress
cdc
differenti
howev
like
repres
one
sever
transcript
factor
regulatori
molecul
eg
microrna
collect
regul
differ
aspect
pdc
develop
express
program
player
known
includ
pdcenrich
transcript
factor
spib
gene
repres
direct
target
although
bind
target
precis
role
pdc
develop
andor
function
remain
establish
other
highli
pdcenrich
transcript
factor
candid
must
character
scratch
final
interest
elucid
epigenet
event
eg
chromatin
modif
accompani
pdc
commit
mainten
activ
simpl
linear
view
pdc
develop
recent
becam
complic
novel
pdcrelat
cdc
subset
mice
identifi
use
marker
unlik
classic
cdc
altern
cdc
develop
independ
transcript
factor
crosspres
antigen
expand
instead
cell
carri
igh
rearrang
typic
pdc
express
mani
pdcrelat
gene
includ
inde
fail
develop
bone
marrow
hand
cdc
secret
ifn
express
significantli
lower
level
pdcspecif
gene
pdc
therefor
altern
cdc
like
split
pdc
lineag
lineag
commit
may
aris
immatur
pdc
fail
termin
differenti
figur
may
repres
either
accident
byproduct
pdc
develop
regul
switch
pdc
cdc
lineag
may
data
emphas
intim
connect
pdc
cdc
develop
identifi
like
default
outcom
pdc
differenti
recent
becom
clear
termin
differenti
state
mani
cell
type
activ
enforc
genet
mechan
thu
remov
singl
transcript
factor
may
caus
loss
lineag
ident
transdifferenti
altern
cell
fate
dramat
exampl
convers
adult
ovari
test
somat
loss
ovaryspecif
transcript
factor
ultim
differenti
immun
cell
lineag
cell
recent
shown
convert
nklike
cell
delet
test
whether
pdc
lineag
show
similar
plastic
delet
matur
pdc
vivo
found
matur
pdc
spontan
differenti
cdclike
cell
acquir
cdc
phenotyp
morpholog
antigenpres
capac
express
profil
differenti
consist
rapid
within
one
week
disappear
peripher
pdc
delet
similar
less
pronounc
drift
toward
cdc
phenotyp
observ
pdc
like
underli
deplet
aberr
phenotyp
impair
function
pdc
mice
human
patient
thu
continu
express
requir
maintain
lineag
ident
pdc
prevent
spontan
differenti
cdclike
cell
result
demonstr
pdc
cell
fate
revers
principl
rais
question
whether
lineag
plastic
may
occur
real
life
notabl
cdclike
cell
deriv
pdc
express
yet
preferenti
upregul
cdcenrich
gene
resembl
altern
cdc
subset
although
latter
cdc
subset
like
deriv
earli
stage
pdc
develop
rather
matur
peripher
pdc
may
repres
common
outcom
natur
genet
induc
pdctocdc
convers
figur
anoth
potenti
instanc
convers
may
occur
pdc
activ
discuss
constantli
expand
varieti
immun
cell
type
longer
describ
simpl
lymphoidversusmyeloid
dichotomi
rather
compris
continu
spectrum
two
side
instanc
novel
innat
effector
cell
type
describ
appear
similar
hematopoiet
stemprogenitor
cell
thu
defi
convent
lineag
assign
particular
develop
dc
recogn
uniqu
pathway
share
earli
progenitor
monocyt
macrophag
distinct
canon
myelopoiesi
close
affili
pdc
cdc
support
similar
innat
function
common
progenitor
close
relat
geneexpress
profil
activationinduc
differenti
cdc
see
spontan
convers
pdc
cdclike
cell
provid
addit
genet
evid
kinship
cdc
given
e
protein
key
regul
lymphopoiesi
conspicu
lymphoid
featur
pdc
morpholog
like
result
ongo
activ
particular
mani
gene
share
pdc
b
cell
includ
import
transcript
factor
spib
ciita
directli
activ
pdc
thu
pdc
view
dc
lymphocyt
cloth
exemplifi
truli
complex
lineag
ident
evad
simpl
definit
one
excit
question
pdc
biolog
seemingli
simpl
one
molecular
basi
uniqu
power
ifn
secret
capac
although
sever
plausibl
answer
advanc
year
like
cover
part
pictur
fundament
new
insight
expect
given
recent
extens
review
subject
briefli
discuss
sever
factor
contribut
uniqu
pdc
function
secretori
morphologywherea
human
pdc
demonstr
plasmacytoid
morpholog
extens
rough
endoplasm
reticulum
latter
appear
less
promin
murin
sheep
pdc
furthermor
murin
cdc
lack
secretori
morpholog
produc
ifn
level
compar
pdc
stimul
cytoplasm
rna
sensor
inde
master
regul
secretori
function
constitut
activ
requir
pdc
cdc
mice
thu
secretori
morpholog
may
use
adapt
caus
highlevel
ifn
secret
capac
express
studi
use
viru
infect
mice
propos
ifn
secret
pdc
independ
receptor
ifnar
requir
cell
type
induc
express
master
regul
ifn
express
inde
subsequ
studi
show
naiv
pdc
express
steadi
state
howev
ifnarmedi
posit
feedback
still
oper
pdc
particular
requir
ifn
secret
absenc
viral
replic
notabl
transcript
level
severalfold
higher
murin
human
pdc
cell
type
rapid
activ
pdc
may
facilit
posttranscript
mechan
interact
tlr
signal
adaptor
thu
baselin
express
undoubtedli
prime
pdc
rapid
ifn
secret
appear
insuffici
explain
pdcspecif
natur
tlr
signalingth
pathway
appear
predomin
mode
nucleic
acid
sens
pdc
although
addit
dna
sensor
propos
recent
signal
ifninduc
larg
multimer
type
cpg
oligonucleotid
occur
earli
endosom
wherea
monomer
type
b
cpg
transfer
endolysosom
fail
induc
ifn
pdc
uniqu
capabl
retain
type
cpg
earli
endocyt
compart
therebi
enabl
ifn
induct
complex
notabl
cpg
complex
lipid
retain
endosom
enabl
ifn
secret
bone
marrowderiv
cdc
vitro
although
pdc
remain
ifn
produc
respons
complex
vivo
therefor
distinct
endosom
traffickingretent
mechan
like
play
critic
role
ifn
secret
capac
pdc
recent
signal
induc
ifn
oppos
shown
origin
distinct
endosom
compart
lysosomerel
organel
traffick
compart
requir
adaptor
protein
complex
inde
cpgor
virusinduc
ifn
induct
abolish
pdc
remain
elucid
whether
lysosomerel
organel
pdc
preform
andor
uniqu
molecular
featur
transmembran
protein
harbor
predict
target
motif
identifi
forward
genet
screen
essenti
regul
cytokin
secret
pdc
cdc
requir
product
ifn
cytokin
includ
respons
ligand
suggest
broader
role
pdc
function
compon
appear
broadli
express
immun
cell
function
may
involv
addit
pdcenrich
molecular
regul
pdcspecif
endocyt
adaptor
signal
induc
tlr
ligand
myeloid
cell
cdc
thought
promot
antiinflammatori
respons
contrast
mtor
particular
essenti
ifn
product
pdc
specif
promot
activ
nuclear
local
consequ
tlr
signal
thu
distinct
pathway
coupl
tlr
signal
activ
pdc
molecular
compon
pathway
known
may
involv
known
pathway
adaptor
bcap
express
pdc
analysi
mechan
candid
regul
pdcspecif
endocyt
pathway
provid
excit
area
research
near
futur
pdcspecif
receptorssever
membran
protein
rel
pdcspecif
express
shown
promot
ifn
secret
pdc
ctype
lectin
receptor
specif
express
naiv
peripher
pdc
mice
requir
optim
ifn
product
vitro
vivo
homolog
nk
cell
receptor
bind
mhc
class
molecul
b
contain
immunoreceptor
tyrosinebas
inhibitori
motif
thu
mechan
activ
function
pdc
unclear
possibl
act
entir
differ
manner
ifn
respons
eg
regul
distribut
tlr
ligand
endosom
compart
mechan
possibl
function
ortholog
human
pdc
remain
character
anoth
receptor
pdctrem
induc
pdc
upon
activ
propos
facilit
ifn
secret
base
rnai
result
pdctrem
found
complex
plexin
cell
guidanc
receptor
implic
dc
function
traffick
whether
pdctrem
specif
ligand
plexin
ligand
semaphorin
human
ortholog
integr
signal
cascad
question
elucid
togeth
data
highlight
emerg
new
world
novel
pdcspecif
receptor
act
complet
unexpect
way
facilit
ifn
secret
pdc
consist
potenti
danger
uncheck
ifn
secret
multipl
pdcspecif
receptor
inhibit
pdc
function
includ
murin
siglech
human
signal
common
pathway
involv
syk
blnk
signal
attenu
tlrinduc
product
ifn
cytokin
unknown
mechan
recent
signific
neg
pdc
regul
reveal
identif
ligand
ifninduc
membran
protein
directli
restrict
viral
replic
thu
express
provid
neg
feedback
pdc
confirm
success
ifn
signal
also
express
mani
tumor
suggest
like
mechan
tumor
prevent
pdc
activ
escap
tumor
surveil
interestingli
murin
pdc
lack
ortholog
instead
specif
express
possibl
provid
shortcircuit
invert
version
signal
pathway
endogen
ligand
inhibitori
receptor
remain
unknown
although
virus
human
immunodefici
viru
hiv
hepat
b
viru
may
hijack
pathway
inhibit
pdc
function
bind
character
inhibitori
pdc
receptor
ligand
mechan
interfer
pdc
activ
yield
import
insight
pdc
biolog
addit
cytokin
secret
activ
pdc
undergo
characterist
dc
matur
program
involv
upregul
costimulatori
molecul
acquisit
cell
stimul
capac
program
select
engag
type
b
cpg
oligonucleotid
induc
pdc
matur
expens
ifn
secret
matur
program
pdc
specif
mediat
signal
doubledefici
pdc
secret
ifn
fail
undergo
matur
die
respons
cpg
data
illustr
two
distinct
molecular
pathway
lead
ifn
secret
versu
matur
pdc
antigenpres
properti
pdc
review
detail
emerg
conclus
activ
pdc
effici
prime
crossprim
lymphocyt
unlik
cdc
isol
ex
vivo
naiv
anim
pdc
absolut
requir
tlrmediat
activ
effici
antigen
present
cell
activ
antigenpresent
pathway
may
oper
specif
pdc
cdc
proteasomeindepend
endosom
pathway
viral
antigen
crosspresent
cytotox
cell
addit
pdc
differ
cdc
similar
b
cell
continu
synthesi
mhc
class
ii
activ
possibl
facilit
present
virusderiv
peptid
function
consequ
pdcmediat
antigen
present
cell
respons
briefli
discuss
antigen
receptor
trigger
blymphocyt
caus
activ
immedi
effect
prolifer
cytokin
secret
surfac
phenotyp
chang
also
launch
prolong
tightli
regul
differenti
program
program
ultim
lead
acquisit
new
cell
fate
may
requir
thorough
erasur
origin
cell
ident
eg
b
cell
differenti
plasma
cell
thu
lymphocyt
preprogram
lineag
plastic
contrast
myeloid
cell
cdc
known
switch
cell
fate
activ
import
question
whether
activ
pdc
undergo
full
cell
fate
convers
cdc
oppos
mere
function
matur
benchmark
full
convers
would
indic
phenotyp
function
chang
ie
switch
plasmacytoid
dendrit
morpholog
loss
pdc
marker
upregul
cdc
marker
acquisit
naiv
cell
prime
capac
exogen
antigen
pdc
origin
identifi
effici
type
precursor
cdc
human
peripher
blood
inde
matur
human
pdc
cultur
cytokin
andor
activ
stimuli
virus
tlr
ligand
exhibit
full
phenotyp
function
differenti
cdc
although
provid
proof
principl
pdctocdc
convers
evid
event
vivo
scarc
lindstedt
et
al
character
human
dc
popul
resect
tonsil
peripher
blood
notabl
tonsil
appear
contain
minor
intermedi
popul
pdc
cdc
moreov
increas
express
pdcspecif
gene
observ
cdc
tonsil
result
may
reflect
ongo
pdc
differenti
cdc
human
counterpart
mous
cdc
site
activ
chronic
infect
mice
phenotyp
chang
consist
cdc
differenti
loss
increas
describ
adopt
transfer
splenic
pdc
h
inactiv
viru
inject
howev
pdc
purif
scheme
use
time
low
like
includ
cell
type
cdc
precursor
unrel
pdc
subsequ
zuniga
colleagu
provid
compel
case
ifndepend
pdc
convers
cdc
follow
lymphocyt
choriomening
viru
lcmv
infect
vitro
invivo
importantli
pdc
bone
marrow
spleen
capabl
convers
suggest
fulli
matur
peripher
pdc
lost
capac
teleolog
differenti
activ
pdc
cdc
would
appear
desir
plausibl
would
automat
termin
highlevel
ifn
secret
shorten
life
span
infect
pdc
time
would
facilit
cell
prime
viral
antigen
addit
pdc
differenti
altern
cdc
subset
develop
delet
discuss
suggest
possibl
fate
activ
fact
express
reduc
severalfold
pdc
activ
rais
possibl
event
may
drive
convers
cdc
thu
cell
fate
convers
activ
pdc
appear
like
await
clear
demonstr
natur
infect
model
major
effector
cell
type
immun
pdc
implic
nearli
normal
patholog
immun
respons
exampl
import
role
pdc
suggest
allergi
asthma
antitumor
immun
respons
nonvir
pathogen
briefli
review
three
relat
aspect
pdc
function
immun
role
cell
respons
versu
toler
antivir
immun
respons
autoimmun
capac
pdc
prime
product
cell
respons
infect
immun
well
document
instanc
pdc
effici
prime
cell
respons
lymph
node
induc
polar
prime
crossprim
cell
respons
result
consist
postul
role
pdc
key
sensor
immun
system
activ
viral
infect
intriguingli
opposit
tolerogen
role
propos
pdc
sever
system
mostli
associ
induct
regulatori
cell
treg
thu
human
pdc
induc
cell
differenti
treg
vitro
vivo
pdc
propos
promot
treg
differenti
human
thymu
induc
tregmedi
toler
tumorbear
mice
toler
cardiac
allograft
experiment
autoimmun
encephalomyel
eae
graftversushost
diseas
studi
howev
phenotyp
definit
pdc
question
instanc
indoleamin
pdc
tumordrain
lymph
node
like
correspond
b
cell
similar
phenotyp
model
graftversushost
diseas
cell
stimulatori
function
pdc
subsequ
demonstr
interest
recent
studi
suggest
import
role
liver
pdc
oral
toler
induct
larg
cell
clonal
delet
thu
tolerogen
andor
treginduc
properti
pdc
may
relev
certain
immun
respons
like
organdepend
fashion
howev
appear
far
univers
conclus
proven
present
thu
broad
definit
steadyst
pdc
tolerogen
would
prematur
mislead
human
pdc
extens
studi
hiv
chronic
viral
hepat
particularli
hepat
c
viru
hcv
infect
emerg
pictur
suggest
import
role
pdc
infect
although
exact
mechan
consequ
pdc
activ
controversi
present
shown
recent
pdc
respond
hcv
particularli
hcvinfect
hepatocyt
hcv
may
specif
impair
pdc
activ
therebi
compromis
cell
respons
howev
studi
demonstr
normal
pdc
function
per
cell
basi
chronic
hcv
resolut
controversi
would
establish
pdc
either
weak
link
antihcv
immun
respons
potenti
power
effector
type
har
immunotherapi
chronic
hcv
hiv
recent
review
clear
pdc
infect
viru
andor
respond
robust
ifn
secret
furthermor
pdc
progress
deplet
blood
infect
patient
either
infectioninduc
death
due
redistribut
lymphoid
organ
key
unresolv
question
whether
hivinduc
pdc
activ
benefici
harm
host
one
hand
ifn
secret
pdc
shown
inhibit
viral
replic
cell
promot
pdc
cdc
matur
lead
kill
infect
cell
inde
hiv
may
evolv
mechan
suppress
pdc
activ
eg
ligat
hand
function
pdc
may
exacerb
cell
deplet
eg
dissemin
hiv
uninfect
cell
bystand
cell
kill
importantli
elev
ifn
respons
pdc
may
contribut
chronic
immun
activ
faster
cell
deplet
eg
femal
compar
male
patient
primat
speci
suscept
simian
immunodefici
viru
plausibl
function
pdc
hiv
infect
chang
protect
pathogen
diseas
progress
earli
stage
infect
ifn
product
viru
crosspresent
pdc
may
help
limit
viru
spread
mount
cytotox
cell
respons
viru
replic
escap
control
ifn
secret
may
drive
polyclon
cell
hyperactiv
deplet
eventu
loss
redistribut
function
impair
pdc
late
stage
infect
would
contribut
immunodefici
thu
role
pdc
hiv
infect
highlight
power
danger
pdc
activ
reveal
yet
anoth
strategi
immun
system
subvers
hiv
given
power
pdc
respons
nearli
envelop
virus
indispens
role
antivir
immun
respons
would
anticip
howev
appear
surprisingli
difficult
demonstr
exampl
pdc
produc
ifn
respons
vesicular
stomat
viru
influenza
viru
yet
appear
dispens
control
vivo
similarli
pdc
primari
ifn
produc
lcmv
infect
requir
optim
ifn
product
viru
clearanc
cell
respons
acut
lcmv
infect
deplet
pdc
impair
ifn
respons
murin
cytomegaloviru
affect
net
nk
cell
respons
overal
surviv
topic
viral
infect
respiratori
syncyti
viru
lung
herp
simplex
viru
vagina
pdc
deplet
lead
severalfold
increas
viral
titer
exacerb
tissu
patholog
perhap
bestdocu
model
pdcdepend
antivir
immun
respons
mous
hepat
viru
mhv
infect
acut
diseas
requir
ifn
viru
clearanc
ludewig
colleagu
show
pdc
deplet
nearli
abolish
ifn
respons
mhv
increas
viral
replic
spleen
caus
viru
spread
normal
protect
tissu
sever
exacerb
liver
damag
macrophag
cdc
shown
major
beneficiari
protect
confer
pdcsecret
ifn
estim
singl
splenic
pdc
protect
macrophag
thu
requir
pdc
antivir
respons
appear
variabl
singl
model
primarili
pdcdepend
protect
describ
date
like
antivir
respons
robust
therefor
involv
multipl
redund
mechan
viru
sens
ifn
secret
howev
addit
acut
ifn
respons
virus
role
pdc
longterm
protect
cell
respons
remain
investig
interestingli
chronic
lcmv
infect
impair
ifn
secret
capac
pdc
unknown
mechan
suggest
normal
pdc
function
would
detriment
lcmv
persist
possibl
facilit
cytotox
cell
respons
studi
direct
would
requir
specif
longterm
approach
pdc
deplet
diphtheria
toxinbas
transgen
model
emerg
elev
ifn
level
pathogenesi
factor
sever
autoimmun
diseas
potenti
import
role
pdc
autoimmun
recogn
date
strongest
evid
pdc
involv
accumul
studi
two
diseas
psoriasi
system
lupu
erythematosu
review
psoriasi
earli
skin
lesion
highli
infiltr
activ
pdc
correspond
decreas
number
circul
pdc
blood
block
ifn
product
pdc
use
antibodi
inhibit
develop
skin
lesion
xenograft
model
provid
causal
proof
pdc
function
diseas
subsequ
gilliet
et
al
identifi
activ
stimulu
pdc
complex
selfdna
antimicrobi
peptid
possibl
homolog
protein
promot
aggreg
releas
cellular
dna
rna
larg
complex
effici
activ
pdc
although
origin
immunostimulatori
complex
consequ
pdc
activ
remain
elucid
major
role
pdc
psoriasi
appear
well
establish
similarli
lupu
patient
show
decreas
circul
pdc
accumul
activ
ifnproduc
pdc
affect
tissu
skin
hallmark
lupu
product
antinuclear
antibodi
immun
complex
antibodi
endogen
nucleic
acid
shown
activ
pdc
complex
may
deliv
endosom
compart
pdc
via
fc
receptor
stimulatori
capac
augment
nuclear
dnabind
protein
addit
selfdna
form
complex
antimicrobi
peptid
releas
neutrophil
result
complex
induc
ifn
secret
pdc
gilliet
person
commun
notabl
tlractiv
pdc
becom
resist
glucocorticoid
could
underli
limit
efficaci
drug
lupu
direct
causal
relationship
pdcderiv
ifn
lupu
progressionsever
hard
establish
human
system
await
elucid
anim
model
nevertheless
like
connect
format
nucleic
acidcontain
immun
complex
pdc
activ
ifn
secret
pronounc
ifn
signatur
diseas
make
strong
case
pdc
major
player
lupu
pathogenesi
overal
aberr
convers
selfnucl
acid
ligand
pdc
via
immun
complex
format
antimicrobi
peptid
bind
mechan
discov
may
repres
common
pathogenesi
step
psoriasi
lupu
possibl
autoimmun
diseas
syndrom
role
pdc
experiment
autoimmun
model
poorli
understood
present
instanc
studi
use
antibodymedi
pdc
ablat
yield
conflict
result
eae
anim
select
loss
mhc
class
ii
express
sever
cell
type
use
demonstr
antiinflammatori
role
pdc
howev
strictli
pdcspecif
genet
loss
mhc
express
andor
function
requir
fulli
elucid
issu
similarli
result
pdc
ablat
nod
model
type
diabet
remain
reconcil
studi
field
conflict
data
may
reflect
specif
effici
issu
transient
pdc
ablat
emphas
necess
deplet
function
manipul
pdc
long
term
abil
would
prerequisit
analysi
pdc
spontan
chronic
autoimmun
diseas
lupu
suscept
mous
strain
appear
play
oppos
role
lupu
pathogenesi
would
interest
dissect
net
contribut
doubleedg
cell
type
come
year
bring
import
insight
key
open
question
pdc
biolog
regul
pdc
lineag
commit
homeostasi
plastic
molecular
basi
uniqu
ifnsecret
capac
pdc
tissueand
immun
responsespecif
role
pdc
cell
activ
toler
precis
function
pdc
infecti
immun
autoimmun
diseas
approach
involv
crossspeci
gene
express
function
analysi
forward
genet
screen
vivo
target
ablat
facilit
research
direct
grow
evid
import
ifn
product
aspect
immun
pdc
emerg
prime
target
immunotherapi
case
chronic
viral
infect
andor
immunodefici
control
enhanc
pdc
function
would
appear
benefici
one
possibl
approach
combin
tlr
stimuli
growth
factor
preferenti
engag
pdc
eg
cpg
respect
vaccin
adjuv
anoth
futur
direct
engag
activ
pdcspecif
receptor
suchasp
dctrem
convers
autoimmun
diseas
lupu
psoriasi
may
benefit
target
inhibit
chronic
pdc
activ
addit
broader
approach
target
ifn
signal
ifn
product
one
might
envisag
therapi
target
specif
pdc
ligat
pdcspecif
inhibitori
receptor
target
uniqu
endocyt
machineri
pdc
case
insight
basic
pdc
biolog
like
fuel
translat
research
pave
way
novel
immunotherapi
propos
scheme
pdc
develop
relationship
cdc
pdc
develop
bone
marrow
continuum
ckit
low
progenitor
includ
lymphoid
progenitor
dark
gray
common
dc
progenitor
cdp
light
blue
develop
proce
put
commit
pdc
progenitor
dash
magenta
immatur
pdc
bone
marrow
toward
matur
peripher
pdc
cdp
give
rise
peripher
cdc
dark
blue
wherea
immatur
bone
marrow
pdc
differenti
cdc
upon
virusinduc
activ
altern
dc
purpl
develop
pdc
progenitor
steadi
state
similar
cell
gener
matur
pdc
induc
delet
possibl
upon
activ
infer
rel
amount
e
protein
inhibitor
indic
cell
type
